{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:37:42Z","timestamp":1789144662201,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10620-020-06142-4","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T12:02:57Z","timestamp":1582027377000},"page":"3726-3733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis"],"prefix":"10.1007","volume":"65","author":[{"given":"Waseem","family":"Amjad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Alukal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliana","family":"Doycheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Thuluvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"key":"6142_CR1","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","volume":"360","author":"MR Lucey","year":"2009","unstructured":"Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758\u20132769.","journal-title":"N Engl J Med."},{"key":"6142_CR2","unstructured":"Young-Hee Y, Chen CM. Liver cirrhosis mortality in the United States: National, state and regional trends. 2000\u20132013. National Institute on Alcohol Abuse and Alcoholism Division of Epidemiology and Prevention Research Alcohol Epidemiologic Data System (105). https:\/\/pubs.niaaa.nih.gov\/publications\/surveillance105\/Cirr13.htm."},{"key":"6142_CR3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2019.2276","volume":"321","author":"T Wong","year":"2019","unstructured":"Wong T, Dang K, Ladhani S, Singal AK, Wong RJ. Prevalence of alcoholic fatty liver disease among adults in the United States, 2001\u20132016. JAMA. 2019;321:1723-1725.","journal-title":"JAMA."},{"key":"6142_CR4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cgh.2017.12.017","volume":"16","author":"G Cholankeril","year":"2018","unstructured":"Cholankeril G, Gonzalez HC, Satapathy SK, et al. Increased waitlist mortality and lower rate for liver transplantation in hispanic patients with primary biliary cholangitis. Clin Gastroenterol Hepatol. 2018;16:965\u2013973.e2..","journal-title":"Clin Gastroenterol Hepatol."},{"key":"6142_CR5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2010.07.016","volume":"54","author":"TD Sandahl","year":"2011","unstructured":"Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H. Incidence and mortality of alcoholic hepatitis in Denmark 1999\u20132008: a nationwide population based cohort study. J Hepatol. 2011;54:760-764.","journal-title":"J Hepatol."},{"key":"6142_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","volume":"75","author":"WC Maddrey","year":"1978","unstructured":"Maddrey WC, Boitnott JK, Bedine MS, Weber FLJ, Mezey E, White RIJ. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193\u2013199.","journal-title":"Gastroenterology."},{"key":"6142_CR7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2017.09.013","volume":"68","author":"SR Lieber","year":"2018","unstructured":"Lieber SR, Rice JP, Lucey MR, Bataller R. Controversies in clinical trials for alcoholic hepatitis. J Hepatol. 2018;68:586\u2013592.","journal-title":"J Hepatol."},{"key":"6142_CR8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"RS O\u2019Shea","year":"2010","unstructured":"O\u2019Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology. 2010;51:307\u2013328.","journal-title":"Hepatology."},{"issue":"2","key":"6142_CR9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","volume":"57","author":"EASL Clinical Practical Guidelines","year":"2012","unstructured":"EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012;57:399\u2013420.","journal-title":"J Hepatol."},{"key":"6142_CR10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","volume":"155","author":"A Louvet","year":"2018","unstructured":"Louvet A, Thursz MR, Kim DJ, et al. Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo\u2014a meta-analysis of individual data from controlled trials. Gastroenterology. 2018;155:458\u2013468.e8.","journal-title":"Gastroenterology."},{"key":"6142_CR11","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","volume":"66","author":"A Louvet","year":"2017","unstructured":"Louvet A, Labreuche J, Artru F, et al. Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study. Hepatology. 2017;66:1464\u20131473.","journal-title":"Hepatology."},{"key":"6142_CR12","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","volume":"365","author":"E Nguyen-Khac","year":"2011","unstructured":"Nguyen-Khac E, Thevenot T, Piquet M-A, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med. 2011;365:1781\u20131789.","journal-title":"N Engl J Med."},{"key":"6142_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","volume":"113","author":"AK Singal","year":"2018","unstructured":"Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG clinical guideline: alcoholic liver disease. Am J Gastroenterol. 2018;113:175\u2013194.","journal-title":"Am J Gastroenterol."},{"key":"6142_CR14","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","volume":"45","author":"A Louvet","year":"2007","unstructured":"Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348-1354.","journal-title":"Hepatology."},{"key":"6142_CR15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"PS Kamath","year":"2007","unstructured":"Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797\u2013805.","journal-title":"Hepatology."},{"key":"6142_CR16","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","volume":"54","author":"EH Forrest","year":"2005","unstructured":"Forrest EH, Evans CDJ, Stewart S, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005;54:1174\u20131179.","journal-title":"Gut."},{"key":"6142_CR17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u2013612.","journal-title":"Ann Intern Med."},{"key":"6142_CR18","first-page":"1","volume":"2159","author":"C Guo","year":"2018","unstructured":"Guo C, So Y. Cause-specific analysis of competing risks using the PHREG procedure. SAS Glob Forum. 2018;2159:1\u201318.","journal-title":"SAS Glob Forum."},{"key":"6142_CR19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u2013845.","journal-title":"Biometrics."},{"issue":"4","key":"6142_CR20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","volume":"44","author":"M Phillips","year":"2006","unstructured":"Phillips M, Curtis H, Portmann B, Donaldson N, Bomford A, O\u2019Grady J. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis\u2014a randomised clinical trial. J Hepatol. 2006;44:784\u2013790.","journal-title":"J Hepatol."},{"key":"6142_CR21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","volume":"37","author":"E Christensen","year":"1995","unstructured":"Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut. 1995;37:113-118.","journal-title":"Gut"},{"key":"6142_CR22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","volume":"27","author":"A Rambaldi","year":"2008","unstructured":"Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C. Systematic review: glucocorticosteroids for alcoholic hepatitis\u2014a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther. 2008;27:1167-1178.","journal-title":"Aliment Pharmacol Ther."},{"key":"6142_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","volume":"60","author":"P Mathurin","year":"2011","unstructured":"Mathurin P, O\u2019Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60:255-260.","journal-title":"Gut."},{"key":"6142_CR24","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","volume":"372","author":"MR Thursz","year":"2015","unstructured":"Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619-1628.","journal-title":"N Engl J Med."},{"key":"6142_CR25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","volume":"53","author":"C Moreno","year":"2010","unstructured":"Moreno C, Langlet P, Hittelet A, et al. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. J Hepatol. 2010;53:1117-1122.","journal-title":"J Hepatol."},{"key":"6142_CR26","first-page":"683","volume":"149","author":"S Sherlock","year":"1988","unstructured":"Sherlock S. Liver disease in women. Alcohol, autoimmunity, and gallstones. West J Med. 1988;149:683\u2013686.","journal-title":"West J Med."},{"key":"6142_CR27","first-page":"633","volume":"9","author":"J Guy","year":"2013","unstructured":"Guy J, Peters MG. Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. Gastroenterol Hepatol (N Y). 2013;9:633-639.","journal-title":"Gastroenterol Hepatol (N Y)."},{"key":"6142_CR28","doi-asserted-by":"crossref","first-page":"624675","DOI":"10.1155\/2012\/624675","volume":"2012","author":"N Palaniyappan","year":"2012","unstructured":"Palaniyappan N, Subramanian V, Ramappa V, Ryder SD, Kaye P, Aithal GP. The utility of scoring systems in predicting early and late mortality in alcoholic hepatitis: whose score is it anyway? Int J Hepatol 2012;2012:624675.","journal-title":"Int J Hepatol"},{"key":"6142_CR29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/apt.12654","volume":"39","author":"V Papastergiou","year":"2014","unstructured":"Papastergiou V, Tsochatzis EA, Pieri G, et al. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther. 2014;39:721\u2013732.","journal-title":"Aliment Pharmacol Ther."},{"key":"6142_CR30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2015.04.044","volume":"149","author":"A Louvet","year":"2015","unstructured":"Louvet A, Labreuche J, Artru F, et al. Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis. Gastroenterology. 2015;149:397-398.","journal-title":"Gastroenterology."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06142-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-020-06142-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06142-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T05:33:20Z","timestamp":1613712800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-020-06142-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6142"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06142-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"assertion":[{"value":"12 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the IRB (MMC 2019-14). The study was in compliance with all ethical standards, and all investigators have participated in it.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was not applicable as this was a retrospective study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}